Lumicell

Call Directions Website

Lumicell Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Lumicell, Health/Medical/ Pharmaceuticals, 307 Waverley Oaks Road, Suite 309, Waltham, MA.

Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce healthcare costs.

Proud to support the next generation of breast surgeons. 💙Lumicell is proud to be a supporter of the ASBrS Breast Fello...
10/06/2026

Proud to support the next generation of breast surgeons. 💙

Lumicell is proud to be a supporter of the ASBrS Breast Fellows University (BFU)—an important opportunity to help advance education, collaboration, and innovation in breast surgical care.

We’re honored to support fellows as they learn, connect with peers and leaders in the field, and continue shaping the future of breast surgery.

🎀 Breast Cancer Awareness Month is here.But at Lumicell, our commitment to breast cancer doesn’t begin in October—and it...
10/01/2026

🎀 Breast Cancer Awareness Month is here.

But at Lumicell, our commitment to breast cancer doesn’t begin in October—and it doesn’t end when the month does. Every day, we’re working to advance breast cancer surgery through innovation designed to help bring greater clarity and confidence to the operating room.

This month, we’re shining an even brighter light on the people at the heart of everything we do: patients, families, and the clinicians who care for them. A breast cancer diagnosis can bring uncertainty at every step. We believe patients deserve to feel informed and supported, and surgeons deserve technology that can help them see more during breast-conserving surgery.

Because every patient deserves to feel supported.
Every question deserves to be heard.
And every step forward deserves a little more light.

This October and every month, we’re committed to bringing the light. 💡

09/22/2026

How is LumiSystem different from traditional methods of identifying residual cancer during surgery?

"That’s very simple to answer. There is nothing like this." — Barry Rosen, MD, FACS

▶️ Watch Dr. Rosen explain why LumiSystem helps surgeons interrogate the lumpectomy cavity to help them determine if they got it all.

Dr. Rosen was compensated by Lumicell to participate in this interview. Please see Important Safety Information in the video.

09/17/2026

Technology is changing what’s possible in the operating room—and giving surgeons new tools to make more informed decisions in real time.

From advancing surgical techniques to innovations like LumiSystem®, the future of breast surgery is about equipping surgeons with better information when it matters most: in real time.

Join MD, PhD, and Jean-Claude Schwartz, MD, PhD, course directors of , for an exclusive webinar to learn more!

📅 September 30, 2026
🕖 7:00 PM EST
Register today: https://www.sirius-medical.com/registration-for-uobc-webinar

Important Safety Information: Serious hypersensitivity reactions, including anaphylaxis, can occur during or following administration of LUMISIGHT (pegulicianine). Anaphylaxis has occurred in 4/726 (0.6%) of patients in clinical studies. LUMISIGHT is contraindicated in patients with a history of hypersensitivity reactions to pegulicianine. Please see the full Prescribing Information, including Boxed Warning, and Instructions for Use at www.LumiSystem.com.

We're excited to be exhibiting at Aptitude Health TME Take the Lead in Breast Cancer Care 2026 Fall Summit 9/24-9/26 an...
09/14/2026

We're excited to be exhibiting at Aptitude Health TME Take the Lead in Breast Cancer Care 2026 Fall Summit 9/24-9/26 and look forward to connecting with the breast surgery community.

As breast cancer care continues to evolve, collaboration, education, and innovation remain essential to improving the surgical experience for both patients and clinicians. If you're attending, be sure to stop by Table 24 to meet the Lumicell team and learn how LumiSystem™ is helping surgeons detect residual breast cancer in real time during lumpectomy, supporting more informed intraoperative decision-making.

Additionally, join us for dinner on Thursday evening for an opportunity to connect with colleagues, discuss the latest advances in breast-conserving surgery, and share ideas in a relaxed setting. Contact [email protected] to RSVP.

We look forward to seeing you at TME!

Important Safety Information: Serious hypersensitivity reactions, including anaphylaxis, can occur during or following administration of LUMISIGHT (pegulicianine). Anaphylaxis has occurred in 4/726 (0.6%) of patients in clinical studies. LUMISIGHT is contraindicated in patients with a history of hypersensitivity reactions to pegulicianine. Please see the full Prescribing Information, including Boxed Warning, and Instructions for Use at www.LumiSystem.com.

We are excited to share that Lumicell’s VP of Innovation, Brian Schlossberg, PhD, will be presenting at the World Molecu...
09/08/2026

We are excited to share that Lumicell’s VP of Innovation, Brian Schlossberg, PhD, will be presenting at the World Molecular Imaging Congress 2026!

💡 Navigating FDA Combination Product Pathway and Reimbursement: Lessons from Lumicell's Experience in Fluorescence-Guided Surgery
📅 Wednesday, September 9
📍 Calvin L. Rampton Salt Palace Convention Center, Salt Lake City, Utah
⏰ 4:15 – 4:40 PM MT

Brian will share Lumicell’s experience bringing LumiSystem® from early feasibility through FDA approval and post-approval reimbursement—offering practical lessons on regulatory strategy, clinical trial design, FDA engagement, and the importance of integrating reimbursement planning early in the development process.

Learn more here: https://www.xcdsystem.com/wmis/program/e7ArcH9/index.cfm?pgid=3280&RunRemoveSessionFilter=1 and join us at .

Important Safety Information: Serious hypersensitivity reactions, including anaphylaxis, can occur during or following administration of LUMISIGHT (pegulicianine). Anaphylaxis has occurred in 4/726 (0.6%) of patients in clinical studies. LUMISIGHT is contraindicated in patients with a history of hypersensitivity reactions to pegulicianine. Please see the full Prescribing Information, including Boxed Warning, and Instructions for Use at www.LumiSystem.com.

This Labor Day, we’re celebrating the people who make a difference every day.From healthcare professionals working tirel...
09/07/2026

This Labor Day, we’re celebrating the people who make a difference every day.

From healthcare professionals working tirelessly to advance patient care to the teams behind the innovation that moves medicine forward, we’re grateful for the dedication, expertise, and hard work that make progress possible.

Wishing everyone a safe and happy Labor Day! ❤️🤍💙

08/31/2026

What happens after the tumor is removed can be just as important as removing the tumor itself.

Even after a successful lumpectomy, residual cancer can remain in the surgical cavity—sometimes leading to additional surgery.

In this conversation, Dr. Barry Rosen explains why fluorescence in the lumpectomy cavity is important and how LumiSystem® provides surgeons with real-time information that wasn't previously available to help lower re-excision rates.

Understanding what's happening in the cavity is changing the conversation around breast-conserving surgery—and helping surgeons make more informed intraoperative decisions.

🎥Watch here

Dr. Rosen was compensated by Lumicell to participate in this interview. Please see Important Safety Information in the video.

08/17/2026

"What we've been missing, which we now have with the LumiSystem, is that we can inject a drug into the patient and that can make their cancers fluoresce."
— Barry Rosen, MD, FACS

For years, breast surgeons have relied on the best available techniques to achieve complete tumor removal during lumpectomy. Today, fluorescence-guided imaging is providing another layer of intraoperative information.

In this clip, explains how LumiSystem® enables surgeons to visualize residual cancer in the lumpectomy cavity during surgery—helping identify cancerous tissue that may otherwise go undetected.

▶️ Watch Dr. Rosen explain why this innovation has the potential to change the future of breast-conserving surgery.

Dr. Rosen was compensated by Lumicell to participate in this interview. Please see Important Safety Information in the video.

Address

307 Waverley Oaks Road, Suite 309
Waltham, MA
02452

Telephone

+16174041001

Website

, ,

Alerts

Be the first to know and let us send you an email when Lumicell posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category